Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia

Measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) in complete remission is an important prognostic marker, but detection methodology requires optimization. The persistence of mutated NPM1 or FLT3-ITD in the blood of adult patients with AML in first complete remission (CR1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Gege, Dillon, Laura W., Ravindra, Niveditha, Hegde, Pranay S., Andrew, Georgia, Mukherjee, Devdeep, Wong, Zoë, Auletta, Jeffery, El Chaer, Firas, Chen, Evan, Chen, Yi-Bin, Corner, Adam, Devine, Steven M., Iyer, Sunil, Jimenez Jimenez, Antonio Martin, De Lima, Marcos J.G., Litzow, Mark R., Kebriaei, Partow, Spellman, Stephen R, Zeger, Scott L., Page, Kristin M., Hourigan, Christopher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418565/
https://www.ncbi.nlm.nih.gov/pubmed/37577695
http://dx.doi.org/10.1101/2023.07.28.23293166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418565/
https://www.ncbi.nlm.nih.gov/pubmed/37577695
http://dx.doi.org/10.1101/2023.07.28.23293166

Ejemplares similares